Vaxcyte earnings
When PCVX reports, and what its stock did after each report.
Next report
Expected around early February, going by its own filing history. The company has not announced a date yet. Its matching report came Feb 24, 2026 and Feb 25, 2025, after the close.
Who else reports that week: the earnings calendar.
Last report: Nov 4, 2026, 16:08 ET (after the close). The filing on SEC EDGAR ↗
After each report
SEC EDGAR · 1D EODMoves are only shown for reports where we hold closing prices.
- Nov 4, 202616:08 ET · after the close8-K ↗no price dataEPS −$1.99quarter to Sep 30, 2026
- Aug 5, 202616:07 ET · after the close8-K ↗no price dataEPS −$1.97quarter to Jun 30, 2026
- May 6, 202616:08 ET · after the close8-K ↗no price dataEPS −$2.30quarter to Mar 31, 2026
- Feb 24, 202616:14 ET · after the close8-K ↗no price data
- Nov 4, 202516:08 ET · after the close8-K ↗no price dataEPS −$1.56quarter to Sep 30, 2025
- Aug 6, 202516:08 ET · after the close8-K ↗no price dataEPS −$1.22quarter to Jun 30, 2025
- May 7, 202516:03 ET · after the close8-K ↗no price dataEPS −$1.04quarter to Mar 31, 2025
- Feb 25, 202516:04 ET · after the close8-K ↗no price data
- Nov 5, 202416:03 ET · after the close8-K ↗no price dataEPS −$0.83quarter to Sep 30, 2024
- Aug 6, 202416:07 ET · after the close8-K ↗no price dataEPS −$1.10quarter to Jun 30, 2024
- May 8, 202416:08 ET · after the close8-K ↗no price dataEPS −$0.85quarter to Mar 31, 2024
- Feb 27, 202416:02 ET · after the close8-K ↗no price data
- Nov 6, 202316:07 ET · after the close8-K ↗no price dataEPS −$0.91quarter to Sep 30, 2023
- Aug 8, 202316:05 ET · after the close8-K ↗no price dataEPS −$0.70quarter to Jun 30, 2023
- May 8, 202316:13 ET · after the close8-K ↗no price dataEPS −$0.70quarter to Mar 31, 2023
- Feb 27, 202316:04 ET · after the close8-K ↗no price data
Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Prior-session closes only; not a forecast, not advice.